EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 168 filers reported holding EAGLE PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $29,000 | -57.4% | 1,862 | -46.9% | 0.00% | – |
| Q2 2023 | $68,000 | -52.4% | 3,504 | -30.5% | 0.00% | – |
| Q1 2023 | $143,000 | +68.2% | 5,042 | +72.5% | 0.00% | – |
| Q4 2022 | $85,000 | -3.4% | 2,923 | -12.7% | 0.00% | – |
| Q3 2022 | $88,000 | +877.8% | 3,348 | +1590.9% | 0.00% | – |
| Q2 2022 | $9,000 | -78.6% | 198 | -76.8% | 0.00% | – |
| Q1 2022 | $42,000 | -60.4% | 852 | -58.8% | 0.00% | – |
| Q4 2021 | $106,000 | +65.6% | 2,069 | +81.7% | 0.00% | – |
| Q3 2021 | $64,000 | -74.4% | 1,139 | -80.5% | 0.00% | – |
| Q2 2021 | $250,000 | -21.1% | 5,835 | -23.0% | 0.00% | – |
| Q1 2021 | $317,000 | -34.8% | 7,577 | -27.3% | 0.00% | – |
| Q4 2020 | $486,000 | +8.5% | 10,418 | -1.4% | 0.00% | – |
| Q3 2020 | $448,000 | +23.1% | 10,565 | +39.0% | 0.00% | – |
| Q2 2020 | $364,000 | -3.4% | 7,602 | -7.3% | 0.00% | – |
| Q1 2020 | $377,000 | -70.7% | 8,203 | -61.7% | 0.00% | – |
| Q4 2019 | $1,287,000 | +19.4% | 21,426 | +12.4% | 0.00% | – |
| Q3 2019 | $1,078,000 | +41.3% | 19,056 | +39.3% | 0.00% | – |
| Q2 2019 | $763,000 | +10.6% | 13,683 | +0.0% | 0.00% | – |
| Q1 2019 | $690,000 | +2553.8% | 13,682 | +2044.5% | 0.00% | – |
| Q4 2018 | $26,000 | -48.0% | 638 | -11.4% | 0.00% | – |
| Q3 2018 | $50,000 | 0.0% | 720 | +8.6% | 0.00% | – |
| Q2 2018 | $50,000 | -83.4% | 663 | -88.4% | 0.00% | – |
| Q1 2018 | $301,000 | -84.7% | 5,696 | -84.5% | 0.00% | – |
| Q4 2017 | $1,961,000 | -59.2% | 36,714 | -54.4% | 0.00% | -100.0% |
| Q3 2017 | $4,804,000 | +26.3% | 80,559 | +67.1% | 0.00% | +50.0% |
| Q2 2017 | $3,805,000 | +720.0% | 48,217 | +762.2% | 0.00% | – |
| Q1 2017 | $464,000 | +44.5% | 5,592 | +38.1% | 0.00% | – |
| Q4 2016 | $321,000 | -67.5% | 4,049 | -71.3% | 0.00% | -100.0% |
| Q3 2016 | $987,000 | +106.1% | 14,102 | +14.2% | 0.00% | – |
| Q2 2016 | $479,000 | -1.0% | 12,351 | +3.5% | 0.00% | – |
| Q1 2016 | $484,000 | -27.4% | 11,934 | +58.6% | 0.00% | – |
| Q4 2015 | $667,000 | +258.6% | 7,524 | +200.5% | 0.00% | – |
| Q3 2015 | $186,000 | +264.7% | 2,504 | +294.3% | 0.00% | – |
| Q2 2015 | $51,000 | +142.9% | 635 | +27.0% | 0.00% | – |
| Q1 2015 | $21,000 | +162.5% | 500 | 0.0% | 0.00% | – |
| Q4 2014 | $8,000 | +100.0% | 500 | +66.7% | 0.00% | – |
| Q3 2014 | $4,000 | 0.0% | 300 | 0.0% | 0.00% | – |
| Q2 2014 | $4,000 | 0.0% | 300 | 0.0% | 0.00% | – |
| Q1 2014 | $4,000 | – | 300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 113,737 | $3,227 | 0.98% |
| Smith, Graham & Co., Investment Advisors, LP | 236,883 | $6,720,371 | 0.82% |
| Capital Impact Advisors, LLC | 13,607 | $386,031 | 0.47% |
| TANG CAPITAL MANAGEMENT LLC | 80,000 | $2,269,600 | 0.34% |
| BRANDES INVESTMENT PARTNERS, LP | 545,050 | $15,463,069 | 0.33% |
| Watershed Asset Management, L.L.C. | 9,496 | $269,402 | 0.33% |
| Jackson Creek Investment Advisors LLC | 25,164 | $714 | 0.30% |
| SummerHaven Investment Management, LLC | 18,178 | $515,710 | 0.30% |
| Virtus Fund Advisers, LLC | 1,117 | $31,689 | 0.22% |
| Virtus Investment Advisers, Inc. | 7,308 | $207,328 | 0.14% |